This association persisted, regardless of the presence of Ser161Ala, Thr288Ala, or Ser291Ala mutations (Fig. 4D), indicating that point mutations did not influence the association between GALNT14 and PHB2 in HCC cells. This evidence concerns the gene GALNT14 and hepatocellular carcinoma.